Long‐term overall survival and toxicities of ABVD vs BEACOPP in advanced Hodgkin lymphoma: A pooled analysis of four randomized trials

Autor: Marc P. E. André, Patrice Carde, Simonetta Viviani, Monica Bellei, Catherine Fortpied, Martin Hutchings, Alessandro M. Gianni, Pauline Brice, Olivier Casasnovas, Paolo G. Gobbi, Pier Luigi Zinzani, Jehan Dupuis, Emilio Iannitto, Alessandro Rambaldi, Josette Brière, Laurianne Clément‐Filliatre, Marian Heczko, Pinuccia Valagussa, Jonathan Douxfils, Julien Depaus, Massimo Federico, Nicolas Mounier

Publikováno v: Cancer Medicine, Vol 9, Iss 18, Pp 6565-6575 (2020)

Abstract Purpose We explored the potential overall survival (OS) benefit of bleomycin, etoposide, doxorubicin (Adriamycin), cyclophosphamide, vincristine (Oncovin), procarbazine, and prednisone (BEACOPP) over doxorubicin (Adriamycin), bleomycin, vinb

Externí odkaz: https://doaj.org/article/937d510df6514257a183dcff6818f98b

Practice guidelines for the management of extranodal non-Hodgkin’s lymphomas of adult non-immunodeficient patients. Part I: primary lung and mediastinal lymphomas. A project of the Italian Society of Hematology, the Italian Society of Experimental Hematology and the Italian Group for Bone Marrow Transplantation

Autor: Pier Luigi Zinzani, Maurizio Martelli, Venerino Poletti, Umberto Vitolo, Paolo G. Gobbi, Tommaso Chisesi, Giovanni Barosi, Andrés J.M. Ferreri, Monia Marchetti, Nicola Pimpinelli, Sante Tura

Publikováno v: Haematologica, Vol 93, Iss 9 (2008)

Extranodal non-Hodgkin’s lymphomas constitute 20–25% of overall non-Hodgkin’s lymphomas cases and can be managed with very different therapeutic strategies. Therefore, the Italian Society of Hematology and the two affiliate societies (the Itali

Externí odkaz: https://doaj.org/article/5f5c667739d14ababb87ad8217a9d219

Secondary malignancies after treatment for indolent non-Hodgkin’s lymphoma: a 16-year follow-up study

Autor: Stefano Sacchi, Luigi Marcheselli, Alessia Bari, Raffaella Marcheselli, Samantha Pozzi, Stefano Luminari, Marco Lombardo, Gabriele Buda, Antonio Lazzaro, Paolo G. Gobbi, Caterina Stelitano, Fortunato Morabito, Giovanni Quarta, Maura Brugiatelli

Publikováno v: Haematologica, Vol 93, Iss 3 (2008)

Background Relatively little information is available on the incidence of secondary cancer in non-Hodgkin’s lymphoma. The aim of this long-term follow-up study was to determine the incidence, the time free of second tumors, and risk factors for dev

Externí odkaz: https://doaj.org/article/deac9396fda34d4ab129ce1c706ef825

Long-term overall survival and toxicities of ABVD vs BEACOPP in advanced Hodgkin lymphoma

Autor: Pier Luigi Zinzani, Julien Depaus, P. Valagussa, Simonetta Viviani, Patrice Carde, Laurianne Clément-Filliatre, Jonathan Douxfils, Marc André, Olivier Casasnovas, Massimo Federico, Pauline Brice, Nicolas Mounier, Alessandro M. Gianni, Paolo G. Gobbi, Jehan Dupuis, Catherine Fortpied, Martin Hutchings, Emilio Iannitto, Monica Bellei, Marian Heczko, Alessandro Rambaldi, Josette Brière

Publikováno v: Cancer Medicine, Vol 9, Iss 18, Pp 6565-6575 (2020)
Cancer Medicine
André, M P E, Carde, P, Viviani, S, Bellei, M, Fortpied, C, Hutchings, M, Gianni, A M, Brice, P, Casasnovas, O, Gobbi, P G, Zinzani, P L, Dupuis, J, Iannitto, E, Rambaldi, A, Brière, J, Clément-Filliatre, L, Heczko, M, Valagussa, P, Douxfils, J, Depaus, J, Federico, M & Mounier, N 2020, ' Long-term overall survival and toxicities of ABVD vs BEACOPP in advanced Hodgkin lymphoma : A pooled analysis of four randomized trials ', Cancer medicine, vol. 9, no. 18, pp. 6565-6575 . https://doi.org/10.1002/cam4.3298
Cancer medicine, Vol. 9, no. 18, p. 6565-6575 (2020)

Purpose We explored the potential overall survival (OS) benefit of bleomycin, etoposide, doxorubicin (Adriamycin), cyclophosphamide, vincristine (Oncovin), procarbazine, and prednisone (BEACOPP) over doxorubicin (Adriamycin), bleomycin, vinblastine,

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c99be92d20b893ec3b515374f66c11fc
https://researchportal.unamur.be/en/publications/2fc7e926-4cf9-4b61-870c-82a9e47fd29a

Neutrophil-lymphocyte ratio at diagnosis is an independent prognostic factor in patients with nodular sclerosis Hodgkin lymphoma: results of a large multicenter study involving 990 patients

Autor: Stefano Sacchi, Luigi Marcheselli, Luca Baldini, Aaron Polliack, Raffaella Marcheselli, Ariel Aviv, Massimo Federico, Sacchi Samantha Pozzi, Maria Christina Cox, Angela Ferrari, Tamar Tadmor, Giuseppe Pugliese, Paolo G. Gobbi, Alessia Bari

Publikováno v: Hematological Oncology. 35:561-566

Several studies have demonstrated the prognostic value of neutrophil-lymphocyte ratio (NLR) in patients with solid tumors and non–Hodgkin lymphoma. In contrast, there is only sparse data on its prognostic role in patients with classical Hodgkin lym

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::914c8b83c777f5e988c4d0534ebe4a1e
https://doi.org/10.1002/hon.2359